Caldwell; Charles G.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Caldwell; Charles G..The latest application filed is for "inhibition of hif-2alpha heterodimerization with hif1beta (arnt)".

Company Profile

0.18.7

Caldwell; Charles G. - Dallas TX
Caldwell; Charles G - Dallas TX
Caldwell; Charles G. - Scotch Plains NJ
Caldwell, Charles G - Scotch Plains NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibition of HIF-2.alpha. heterodimerization with HIF1.beta. (ARNT) Grant 9,757,379 - Bruick , et al. September 12, 2	2017-09-12
Inhibition Of Hif-2alpha Heterodimerization With Hif1beta (arnt) App 20160250216 - BRUICK; Richard K. ; et al.	2016-09-01
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,956,061 - Ashton , et al. June 7, 2	2011-06-07
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes Grant 7,910,596 - Biftu , et al. March 22, 2	2011-03-22
Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20100234403 - Biftu; Tesfaye ; et al.	2010-09-16
Bicyclic Pyrimidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes App 20090105210 - Ashton; Wallace T. ; et al.	2009-04-23
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,388,019 - Ashton , et al. June 17, 2	2008-06-17
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,265,128 - Ashton , et al. September 4, 2	2007-09-04
Pyrrolidine modulators of CCR5 chemokine receptor activity Grant 7,125,887 - Hale , et al. October 24, 2	2006-10-24
Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes Grant 7,026,316 - Ashton , et al. April 11, 2	2006-04-11
3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20060074087 - Ashton; WallaceT ; et al.	2006-04-06
Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes App 20040106656 - Ashton, Wallace T ; et al.	2004-06-03
Pyrrolidine modulators of ccr5 chemokine receptor activity App 20040087552 - Hale, Jeffrey J ; et al.	2004-05-06
Pyrrolidine modulators of chemokine receptor activity Grant 6,498,161 - Caldwell , et al. December 24, 2	2002-12-24
Cyclic amine modulators of chemokine receptor activity Grant 6,476,054 - Caldwell , et al. November 5, 2	2002-11-05
Pyrrolidine modulators of CCR5 chemokine receptor activity App 20020094989 - Hale, Jeffrey J. ; et al.	2002-07-18
Pyrrolidine modulators of chemokine receptor activity Grant 6,399,619 - Berk , et al. June 4, 2	2002-06-04
Cyclic amine modulators of chemokine receptor activity Grant 6,140,349 - Caldwell , et al. October 31, 2	2000-10-31
Cyclic amine modulations of chemokine receptor activity Grant 6,136,827 - Caldwell , et al. October 24, 2	2000-10-24
Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases Grant 6,043,358 - Caldwell , et al. March 28, 2	2000-03-28
Phenyl spiroethercycloalkyl tachykinin receptor antagonists Grant 5,877,191 - Caldwell , et al. March 2, 1	1999-03-02
Cycloalkyl tachykinin receptor antagonists Grant 5,750,549 - Caldwell , et al. May 12, 1	1998-05-12
Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents Grant 5,679,700 - Caldwell , et al. October 21, 1	1997-10-21
Cyclic amidine analogs as inhibitors of nitric oxide synthase Grant 5,629,322 - Guthikonda , et al. May 13, 1	1997-05-13
6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis Grant 4,966,907 - Caldwell , et al. October 30, 1	1990-10-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.